These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 7283508)

  • 1. Pseudo-Zollinger-Ellison syndrome: hypergastrinemia, hyperchlorhydria without tumor.
    Friesen SR; Tomita T
    Ann Surg; 1981 Oct; 194(4):481-93. PubMed ID: 7283508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium and secretin as provocative stimuli in the Zollinger-Ellison syndrome.
    Mihas AA; Hirschowitz BI; Gibson RG
    Digestion; 1978; 17(1):1-10. PubMed ID: 627316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of glucagon provocation test in the diagnosis of hypergastrinemia.
    Nakanome C; Ishimori A; Goto Y; Yamazaki T; Kameyama J; Sasaki I; Inui M; Furukawa Y; Komatsu K
    Gastroenterol Jpn; 1981; 16(3):213-22. PubMed ID: 6114893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum gastrin response to secretin after vagotomy.
    Feldman M; Walsh JH; Richardson CT
    Dig Dis Sci; 1980 Dec; 25(12):921-3. PubMed ID: 7449589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretin and the Zollinger--Ellison syndrome: reliability of secretin tests and pathogenetic role of secretin.
    Stage JG; Stadil F; Rehfeld JF; Fahrenkrug J; Muckadell OB
    Scand J Gastroenterol; 1978; 13(4):501-11. PubMed ID: 675163
    [No Abstract]   [Full Text] [Related]  

  • 6. Secretin-induced gastrin response in the Zollinger-Ellison syndrome and chronic duodenal ulcer patients before and after cimetidine treatment.
    Quatrini M; Basilisco G; Conte D; Bardella MT; Bozzani A; Bianchi PA
    Am J Gastroenterol; 1984 May; 79(5):345-7. PubMed ID: 6720654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum gastrin in Zollinger-Ellison syndrome: II. Prospective study of gastrin provocative testing in 293 patients from the National Institutes of Health and comparison with 537 cases from the literature. evaluation of diagnostic criteria, proposal of new criteria, and correlations with clinical and tumoral features.
    Berna MJ; Hoffmann KM; Long SH; Serrano J; Gibril F; Jensen RT
    Medicine (Baltimore); 2006 Nov; 85(6):331-364. PubMed ID: 17108779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zollinger-Ellison syndrome type 1: clinical and pathological correlations in a case.
    Cowley DJ; Dymock IW; Boyes BE; Wilson RY; Stagg BH; Lewin MR; Polak JM; Pearse AG
    Gut; 1973 Jan; 14(1):25-9. PubMed ID: 4571070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypergastrinemia. Physiopathological and clinical aspects with a study of a series of Zollinger-Ellison cases].
    Fiasse R; De Graef J; Pauwels S; Woussen-Colle MC; Rahier J; Kestens PJ; Dive C
    Acta Gastroenterol Belg; 1982; 45(7-8):293-309. PubMed ID: 6132512
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative study of the value of the calcium, secretin, and meal stimulated increase in serum gastrin to the diagnosis of the Zollinger-Ellison syndrome.
    Lamers CG; Van Tongeren JH
    Gut; 1977 Feb; 18(2):128-35. PubMed ID: 323117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Zollinger-Ellison syndrome].
    Becker HD
    Wien Klin Wochenschr; 1984 Feb; 96(4):138-44. PubMed ID: 6324497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of changes in serum calcium on secretin-stimulated serum gastrin in patients with Zollinger-Ellison syndrome.
    Jansen JB; Lamers CB
    Gastroenterology; 1982 Jul; 83(1 Pt 2):173-8. PubMed ID: 6806138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment and prediction of long-term cure in patients with the Zollinger-Ellison syndrome: the best approach.
    Fishbeyn VA; Norton JA; Benya RV; Pisegna JR; Venzon DJ; Metz DC; Jensen RT
    Ann Intern Med; 1993 Aug; 119(3):199-206. PubMed ID: 8323088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium challenge in the Zollinger-Ellison syndrome.
    Passaro E; Basso N; Walsh JH
    Surgery; 1972 Jul; 72(1):60-7. PubMed ID: 4338199
    [No Abstract]   [Full Text] [Related]  

  • 15. Serum gastrin levels in response to exogenous secretin in patients with duodenal ulcer--false positive response occurring in case of endoscopically active ulcer.
    Shiratori K; Watanabe S; Takeuchi T
    Gastroenterol Jpn; 1982 Apr; 17(2):80-6. PubMed ID: 7106502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secretin provocation test in the diagnosis of Zollinger-Ellison syndrome.
    Brady CE
    Am J Gastroenterol; 1991 Feb; 86(2):129-34. PubMed ID: 1992623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudo-Zollinger--Ellison syndrome in a child presenting with anemia.
    Zaatar R; Younoszai MK; Mitros F
    Gastroenterology; 1987 Feb; 92(2):508-12. PubMed ID: 3792786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical usefulness of the secretin provocation test.
    Lamers CB
    J Clin Gastroenterol; 1981 Sep; 3(3):255-9. PubMed ID: 7288118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum gastrin in duodenal ulcer. I. Basal levels and effect of food and atropine.
    Korman MG; Soveny C; Hansky J
    Gut; 1971 Nov; 12(11):899-902. PubMed ID: 5132220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypergastrinaemia due to an excluded gastric antrum: a proposed method for differentiation from the Zollinger ellison syndrome.
    Korman MG; Scott DF; Hansky J; Wilson H
    Aust N Z J Med; 1972 Aug; 2(3):266-71. PubMed ID: 4508248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.